{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T11:18:55Z","timestamp":1782904735967,"version":"3.54.5"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T00:00:00Z","timestamp":1529366400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100009619","name":"AMED","doi-asserted-by":"crossref","award":["17ck0106340h0001"],"award-info":[{"award-number":["17ck0106340h0001"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Brain Tumor Pathol"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1007\/s10014-018-0321-4","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T12:05:14Z","timestamp":1529409914000},"page":"148-158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Radiological characteristics based on isocitrate dehydrogenase mutations and 1p\/19q codeletion in grade II and III gliomas"],"prefix":"10.1007","volume":"35","author":[{"given":"Takahiro","family":"Yamauchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamichi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuji","family":"Miyakita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Kondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Tsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaishi","family":"Satomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ichimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshitaka","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,19]]},"reference":[{"key":"321_CR1","volume-title":"WHO classification of tumors of the central nervous system revised","author":"DN Louis","year":"2016","unstructured":"Louis DN, Ohgaki H, Webster OD, Cavenee WK, Ellison DW, Figarella-Branger D, Perry A, Reifenberger G, von Deimlimg A (2016) WHO classification of tumors of the central nervous system revised, 4th\u00a0edn. IARC, Lyon","edition":"4"},{"key":"321_CR2","doi-asserted-by":"publisher","first-page":"2499","DOI":"10.1056\/NEJMoa1407279","volume":"372","author":"JE Eckel-Passow","year":"2015","unstructured":"Eckel-Passow JE, Lachance DH, Molinaro AM, Walsh KM, Decker PA, Sicotte H, Pekmezci M, Rice T, Kosel ML, Smirnov IV, Sarkar G, Caron AA, Kollmeyer TM, Praska CE, Chada AR, Halder C, Hansen HM, McCoy LS, Bracci PM, Marshall R, Zheng S, Reis GF, Pico AR, O\u2019Neill BP, Buckner JC, Giannini C, Huse JT, Perry A, Tihan T, Berger MS, Chang SM, Prados MD, Wiemels J, Wiencke JK, Wrensch MR, Jenkins RB (2015) Glioma groups based on 1p\/19q, IDH, and TERT promoter mutations in tumors. N Engl J 372:2499\u20132508","journal-title":"N Engl J"},{"key":"321_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00401-014-1370-3","volume":"129","author":"DE Reuss","year":"2015","unstructured":"Reuss DE, Sahm F, Schrimpf D, Wiestler B, Capper D, Koelsche C, Schweizer L, Korshunov A, Jones DT, Hovestadt V, Mittelbronn M, Schittenhelm J, Herold-Mende C, Unterberg A, Platten M, Weller M, Wick W, Pfister SM, von Deimling A (2015) ATRX and IDH1-R132H immunohistochemistry with subsequent copy number analysis and IDH sequencing as a basis for an \u201cintegrated\u201d diagnostic approach for adult astrocytoma, oligodendroglioma and glioblastoma. Acta Neuropathol 129:133\u2013146","journal-title":"Acta Neuropathol"},{"key":"321_CR4","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1136\/jclinpath-2015-203456","volume":"69","author":"KS Rajmohan","year":"2016","unstructured":"Rajmohan KS, Sugur HS, Shwetha SD, Ramesh A, Thennarasu K, Pandey P, Arivazhagan A, Santosh V (2016) Prognostic significance of histomolecular subgroups of adult anaplastic (WHO Grade III) gliomas: applying the \u2018integrated\u2019 diagnosis approach. J Clin Pathol 69:686\u2013694","journal-title":"J Clin Pathol"},{"key":"321_CR5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s40478-016-0351-2","volume":"4","author":"H Arita","year":"2016","unstructured":"Arita H, Yamasaki K, Matsushita Y, Nakamura T, Shimokawa A, Takami H, Tanaka S, Mukasa A, Shirahata M, Shimizu S, Suzuki K, Saito K, Kobayashi K, Higuchi F, Uzuka T, Otani R, Tamura K, Sumita K, Ohno M, Miyakita Y, Kagawa N, Hashimoto N, Hatae R, Yoshimoto K, Shinojima N, Nakamura H, Kanemura Y, Okita Y, Kinoshita M, Ishibashi K, Shofuda T, Kodama Y, Mori K, Tomogane Y, Fukai J, Fujita K, Terakawa Y, Tsuyuguchi N, Moriuchi S, Nonaka M, Suzuki H, Shibuya M, Maehara T, Saito N, Nagane M, Kawahara N, Ueki K, Yoshimine T, Miyaoka E, Nishikawa R, Komori T, Narita Y, Ichimura K (2016) A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas. Acta Neuropathol Commun 4:79","journal-title":"Acta Neuropathol Commun"},{"key":"321_CR6","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1093\/neuonc\/not235","volume":"16","author":"G Reyes-Botero","year":"2014","unstructured":"Reyes-Botero G, Dehais C, Idbaih A, Martin-Duverneuil N, Lahutte M, Carpentier C, Letouz\u00e9 E, Chinot O, Loiseau H, Honnorat J, Ramirez C, Moyal E, Figarella-Branger D, Ducray F (2014) Contrast enhancement in 1p\/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression. POLA Netw Neuro Oncol 16:662\u2013670","journal-title":"POLA Netw Neuro Oncol"},{"key":"321_CR7","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/ng.3273","volume":"47","author":"H Suzuki","year":"2015","unstructured":"Suzuki H, Aoki K, Chiba K, Sato Y, Shiozawa Y, Shiraishi Y, Shimamura T, Niida A, Motomura K, Ohka F, Yamamoto T, Tanahashi K, Ranjit M, Wakabayashi T, Yoshizato T, Kataoka K, Yoshida K, Nagata Y, Sato-Otsubo A, Tanaka H, Sanada M, Kondo Y, Nakamura H, Mizoguchi M, Abe T, Muragaki Y, Watanabe R, Ito I, Miyano S, Natsume A, Ogawa S (2015) Mutational landscape and clonal architecture in grade II and III gliomas. Nat Genet 47:458\u2013468","journal-title":"Nat Genet"},{"key":"321_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1007\/s00401-015-1409-0","volume":"129","author":"M Weller","year":"2015","unstructured":"Weller M, Weber RG, Willscher E, Riehmer V, Hentschel B, Kreuz M, Felsberg J, Beyer U, L\u00f6ffler-Wirth H, Kaulich K, Steinbach JP, Hartmann C, Gramatzki D, Schramm J, Westphal M, Schackert G, Simon M, Martens T, Bostr\u00f6m J, Hagel C, Sabel M, Krex D, Tonn JC, Wick W, Noell S, Schlegel U, Radlwimmer B, Pietsch T, Loeffler M, von Deimling A, Binder H, Reifenberger G (2015) Molecular classification of diffuse cerebral WHO grade II\/III gliomas using genome- and transcriptome-wide profiling improves stratification of prognostically distinct patient groups. Acta Neuropathol 129:679\u2013693","journal-title":"Acta Neuropathol"},{"key":"321_CR9","doi-asserted-by":"publisher","first-page":"1669","DOI":"10.1148\/rg.256055137","volume":"25","author":"KK Koeller","year":"2005","unstructured":"Koeller KK, Rushing EJ (2005) From the archives of the AFIP: oligodendroglioma and its variants: radiologic-pathologic correlation. Radiographics 25:1669\u20131688","journal-title":"Radiographics"},{"key":"321_CR10","doi-asserted-by":"publisher","DOI":"10.1259\/bjr.20150857","author":"M Smits","year":"2016","unstructured":"Smits M (2016) Imaging of oligodendroglioma. Br J Radiol. \n                    https:\/\/doi.org\/10.1259\/bjr.20150857","journal-title":"Br J Radiol"},{"key":"321_CR11","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.1007\/s007010100014","volume":"143","author":"MA1 Leonardi","year":"2001","unstructured":"Leonardi MA1, Lumenta CB (2001) Oligodendrogliomas in the CT\/MR-era. Acta Neurochir (Wien) 143:1195\u20131203","journal-title":"Acta Neurochir (Wien)"},{"key":"321_CR12","doi-asserted-by":"publisher","first-page":"361","DOI":"10.2214\/ajr.152.2.361","volume":"152","author":"YY Lee","year":"1989","unstructured":"Lee YY, Van Tassel P (1989) Intracranial oligodendrogliomas: imaging findings in 35 untreated cases. AJR Am J Roentgenol 152:361\u2013369","journal-title":"AJR Am J Roentgenol"},{"key":"321_CR13","first-page":"6713","volume":"61","author":"MC Zlatescu","year":"2001","unstructured":"Zlatescu MC, TehraniYazdi A, Sasaki H, Megyesi JF, Betensky RA, Louis DN, Cairncross JG (2001) Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. Cancer Res 61:6713\u20136715","journal-title":"Cancer Res"},{"key":"321_CR14","doi-asserted-by":"publisher","first-page":"852","DOI":"10.3174\/ajnr.A2895","volume":"33","author":"L Khalid","year":"2012","unstructured":"Khalid L, Carone M, Dumrongpisutikul N, Intrapiromkul J, Bonekamp D, Barker PB, Yousem DM (2012) Imaging characteristics of oligodendrogliomas that predict grade. AJNR Am J Neuroradiol 33:852\u2013857","journal-title":"AJNR Am J Neuroradiol"},{"key":"321_CR15","first-page":"784","volume":"26","author":"ML White","year":"2005","unstructured":"White ML, Zhang Y, Kirby P, Ryken TC (2005) Can tumor contrast enhancement be used as a criterion for differentiating tumor grades of oligodendrogliomas? AJNR Am J Neuroradiol 26:784\u2013790","journal-title":"AJNR Am J Neuroradiol"},{"key":"321_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s10014-014-0211-3","volume":"32","author":"Y Sonoda","year":"2015","unstructured":"Sonoda Y, Shibahara I, Kawaguchi T, Saito R, Kanamori M, Watanabe M, Suzuki H, Kumabe T, Tominaga T (2015) Association between molecular alterations and tumor location and MRI characteristics in anaplastic gliomas. Brain Tumor Pathol 32:99\u2013104","journal-title":"Brain Tumor Pathol"},{"key":"321_CR17","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.3892\/ol.2014.2013","volume":"7","author":"S Qi","year":"2014","unstructured":"Qi S, Yu L, Li H, Ou Y, Qiu X, Ding Y, Han H, Zhang X (2014) Isocitrate dehydrogenase mutation is associated with tumor location and magnetic resonance imaging characteristics in astrocytic neoplasms. Oncol Lett 7:1895\u20131902","journal-title":"Oncol Lett"},{"key":"321_CR18","doi-asserted-by":"publisher","first-page":"4303","DOI":"10.1158\/1078-0432.CCR-04-0209","volume":"10","author":"JF Megyesi","year":"2004","unstructured":"Megyesi JF, Kachur E, Lee DH, Zlatescu MC, Betensky RA, Forsyth PA, Okada Y, Sasaki H, Mizoguchi M, Louis DN, Cairncross JG (2004) Imaging correlates of molecular signatures in oligodendrogliomas. Clin Cancer Res 10:4303\u20134306","journal-title":"Clin Cancer Res"},{"key":"321_CR19","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/brain\/awl108","volume":"129","author":"MD Jenkinson","year":"2006","unstructured":"Jenkinson MD, du Plessis DG, Smith TS, Joyce KA, Warnke PC, Walker C (2006) Histological growth patterns and genotype in oligodendroglial tumours: correlation with MRI features. Brain 129:1884\u20131891","journal-title":"Brain"},{"key":"321_CR20","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1136\/jnnp.2009.178806","volume":"82","author":"JW1 Kim","year":"2011","unstructured":"Kim JW1, Park CK, Park SH, Kim YH, Han JH, Kim CY, Sohn CH, Chang KH, Jung HW (2011) Relationship between radiological characteristics and combined 1p and 19q deletion in World Health Organization grade III oligodendroglial tumours. J Neurol Neurosurg Psychiatry 82:224\u2013227","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"321_CR21","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s10014-016-0249-5","volume":"33","author":"T Saito","year":"2016","unstructured":"Saito T, Muragaki Y, Maruyama T, Komori T, Tamura M, Nitta M, Tsuzuki S, Kawamata T (2016) Calcification on CT is a simple and valuable preoperative indicator of 1p\/19q loss of heterozygosity in supratentorial brain tumors that are suspected grade II and III gliomas. Brain Tumor Pathol 33:175\u2013182","journal-title":"Brain Tumor Pathol"},{"key":"321_CR22","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s11060-017-2613-7","volume":"135","author":"RL Delfanti","year":"2017","unstructured":"Delfanti RL, Piccioni DE, Handwerker J, Bahrami N, Krishnan A, Karunamuni R, Hattangadi-Gluth JA, Seibert TM, Srikant A, Jones KA, Snyder VS, Dale AM, White NS, McDonald CR, Farid N (2017) Imaging correlates for the 2016 update on WHO classification of grade II\/III gliomas: implications for IDH, 1p\/19q and ATRX status. J Neurooncol 135:601\u2013609","journal-title":"J Neurooncol"},{"key":"321_CR23","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.3892\/ijo.2012.1564","volume":"41","author":"Y Okita","year":"2012","unstructured":"Okita Y, Narita Y, Miyakita Y, Ohno M, Matsushita Y, Fukushima S, Sumi M, Ichimura K, Kayama T, Shibui S (2012) IDH1\/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy. Int J Oncol 41:1325\u20131336","journal-title":"Int J Oncol"},{"key":"321_CR24","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.cancergencyto.2008.09.017","volume":"190","author":"C Franco-Hernandez","year":"2009","unstructured":"Franco-Hernandez C, Martinez-Glez V, de Campos JM, Isla A, Vaquero J, Gutierrez M, Casartelli C, Rey JA (2009) Allelic status of 1p and 19q in oligodendrogliomas and glioblastomas: multiplex ligation-dependent probe amplification versus loss of heterozygosity. Cancer Genet Cytogenet 190:93\u201396","journal-title":"Cancer Genet Cytogenet"},{"key":"321_CR25","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1215\/15228517-2008-066","volume":"11","author":"J Pallud","year":"2009","unstructured":"Pallud J, Capelle L, Taillandier L, Fontaine D, Mandonnet E, Guillevin R, Bauchet L, Peruzzi P, Laigle-Donadey F, Kujas M, Guyotat J, Baron MH, Mokhtari K, Duffau H (2009) Prognostic significance of imaging contrast enhancement for WHO grade II gliomas. Neuro Oncol 11:176\u2013182","journal-title":"Neuro Oncol"},{"key":"321_CR26","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1002\/cncr.11120","volume":"97","author":"A Tortosa","year":"2003","unstructured":"Tortosa A, Vi\u00f1olas N, Vill\u00e0 S, Verger E, Gil JM, Brell M, Caral L, Pujol T, Acebes JJ, Ribalta T, Ferrer I, Graus F (2003) Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas. Cancer 97:1063\u20131071","journal-title":"Cancer"},{"key":"321_CR27","doi-asserted-by":"publisher","first-page":"4482","DOI":"10.1200\/JCO.2010.33.8715","volume":"29","author":"A Lai","year":"2011","unstructured":"Lai A, Kharbanda S, Pope WB, Tran A, Solis OE, Peale F, Forrest WF, Pujara K, Carrillo JA, Pandita A, Ellingson BM, Bowers CW, Soriano RH, Schmidt NO, Mohan S, Yong WH, Seshagiri S, Modrusan Z, Jiang Z, Aldape KD, Mischel PS, Liau LM, Escovedo CJ, Chen W, Nghiemphu PL, James CD, Prados MD, Westphal M, Lamszus K, Cloughesy T, Phillips HS (2011) Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J Clin Oncol 29:4482\u20134490","journal-title":"J Clin Oncol"},{"key":"321_CR28","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s00401-010-0777-8","volume":"120","author":"P Metellus","year":"2010","unstructured":"Metellus P, Coulibaly B, Colin C, de Paula AM, Vasiljevic A, Taieb D, Barlier A, Boisselier B, Mokhtari K, Wang XW, Loundou A, Chapon F, Pineau S, Ouafik L, Chinot O, Figarella-Branger D (2010) Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis. Acta Neuropathol 120:719\u2013729","journal-title":"Acta Neuropathol"},{"key":"321_CR29","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1634\/theoncologist.2008-0272","volume":"14","author":"AS Chi","year":"2009","unstructured":"Chi AS, Sorensen AG, Jain RK, Batchelor TT (2009) Angiogenesis as a therapeutic target in malignant gliomas. Oncologist 14:621\u2013636","journal-title":"Oncologist"},{"key":"321_CR30","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.3892\/ol.2011.384","volume":"2","author":"Y Liu","year":"2011","unstructured":"Liu Y, Zhou Y, Zhang XS, Shen BZ (2011) Expression of VEGF and MMP-9 and MRI imaging changes in cerebral glioma. Oncol Lett 2:1171\u20131175","journal-title":"Oncol Lett"},{"key":"321_CR31","first-page":"1559","volume":"18","author":"H Nagashima","year":"2016","unstructured":"Nagashima H, Tanaka K, Sasayama T, Irino Y, Sato N, Takeuchi Y, Kyotani K, Mukasa A, Mizukawa K, Sakata J, Yamamoto Y, Hosoda K, Itoh T, Sasaki R, Kohmura E (2016) Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma. Neuro Oncol 18:1559\u20131568","journal-title":"Neuro Oncol"}],"container-title":["Brain Tumor Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10014-018-0321-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-018-0321-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10014-018-0321-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T10:04:04Z","timestamp":1589450644000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10014-018-0321-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,19]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1007\/s10014-018-0321-4","relation":{},"ISSN":["1433-7398","1861-387X"],"issn-type":[{"value":"1433-7398","type":"print"},{"value":"1861-387X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,19]]},"assertion":[{"value":"13 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors report no conflict of interest concerning the materials or methods used in this study or the findings specified in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}